De Luca, Leonardo <br/><br/>
Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study.  [electronic resource] 

 -  Acute cardiac care  2008 
 - 93-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1748-2941 
<br/><br/><label>Standard No.: </label>10.1080/17482940701747063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Coated Materials, Biocompatible<br/>Coronary Angiography<br/>Coronary Restenosis--complications<br/>Diabetes Complications--blood<br/>Double-Blind Method<br/>Elective Surgical Procedures--methods<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Male<br/>Middle Aged<br/>Myocardial Revascularization--instrumentation<br/>Paclitaxel--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Prospective Studies<br/>Stents<br/>Treatment Outcome